
PMC:7029759 / 24007-25423
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
552 | 241-245 | Gene | denotes | ACE2 | Gene:59272 |
553 | 440-444 | Gene | denotes | ACE2 | Gene:59272 |
554 | 564-568 | Gene | denotes | ACE2 | Gene:59272 |
555 | 725-729 | Gene | denotes | ACE2 | Gene:59272 |
556 | 747-751 | Gene | denotes | ACE2 | Gene:59272 |
557 | 825-829 | Gene | denotes | ACE2 | Gene:59272 |
558 | 897-901 | Gene | denotes | ACE2 | Gene:59272 |
559 | 1123-1127 | Gene | denotes | ACE2 | Gene:59272 |
560 | 1181-1185 | Gene | denotes | ACE2 | Gene:59272 |
561 | 1337-1341 | Gene | denotes | ACE2 | Gene:59272 |
562 | 582-583 | Gene | denotes | S | Gene:43740568 |
563 | 278-279 | Gene | denotes | S | Gene:43740568 |
564 | 106-117 | Species | denotes | coronavirus | Tax:11118 |
565 | 291-300 | Species | denotes | 2019-nCoV | Tax:2697049 |
566 | 372-382 | Species | denotes | SARS virus | Tax:694009 |
567 | 484-494 | Species | denotes | SARS virus | Tax:694009 |
568 | 690-699 | Species | denotes | 2019-nCoV | Tax:2697049 |
569 | 774-782 | Species | denotes | patients | Tax:9606 |
570 | 1223-1239 | Species | denotes | SARS coronavirus | Tax:694009 |
571 | 1369-1378 | Species | denotes | 2019-nCoV | Tax:2697049 |
572 | 1407-1415 | Species | denotes | patients | Tax:9606 |
573 | 1162-1167 | Species | denotes | human | Tax:9606 |
574 | 165-173 | Disease | denotes | infected | MESH:D007239 |
575 | 577-581 | Disease | denotes | SARS | MESH:D045169 |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T618 | 60-68 | GO:0042571 | denotes | antibody |
T617 | 74-82 | CHEBI:36357;CHEBI:36357 | denotes | molecule |
T616 | 106-117 | NCBITaxon:11118 | denotes | coronavirus |
T615 | 241-245 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T614 | 278-287 | PG_1 | denotes | S protein |
T613 | 291-300 | SP_7 | denotes | 2019-nCoV |
T612 | 326-331 | NCBITaxon:10239 | denotes | virus |
T611 | 372-376 | SP_10;NCBITaxon:10633 | denotes | SARS |
T610 | 377-382 | NCBITaxon:10239 | denotes | virus |
T609 | 440-444 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T608 | 484-488 | SP_10;NCBITaxon:10633 | denotes | SARS |
T607 | 489-494 | NCBITaxon:10239 | denotes | virus |
T606 | 564-568 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T605 | 577-581 | SP_10;PG_9 | denotes | SARS |
T604 | 582-583 | PG_9;PG_1 | denotes | S |
T603 | 584-591 | PG_1 | denotes | protein |
T602 | 657-667 | GO:0042571 | denotes | antibodies |
T601 | 690-699 | SP_7 | denotes | 2019-nCoV |
T600 | 725-729 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T599 | 747-751 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T598 | 825-829 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T597 | 871-885 | GO:0019814 | denotes | immunoglobulin |
T596 | 889-895 | SO:0000417 | denotes | domain |
T595 | 897-901 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T594 | 929-937 | UBERON:0000104 | denotes | lifespan |
T593 | 957-965 | CHEBI:36357;CHEBI:36357 | denotes | molecule |
T592 | 989-997 | CHEBI:35224;CHEBI:35224 | denotes | effector |
T591 | 1015-1028 | UBERON:0002405 | denotes | immune system |
T590 | 1041-1046 | NCBITaxon:10239 | denotes | virus |
T589 | 1071-1077 | NCBITaxon:33208 | denotes | animal |
T588 | 1123-1127 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T587 | 1128-1141 | GO:0005576 | denotes | extracellular |
T586 | 1142-1148 | SO:0000417 | denotes | domain |
T585 | 1162-1167 | SP_6;NCBITaxon:9606 | denotes | human |
T584 | 1173-1179 | SO:0000417 | denotes | domain |
T583 | 1181-1185 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T582 | 1223-1227 | SP_10 | denotes | SARS |
T581 | 1228-1239 | NCBITaxon:11118 | denotes | coronavirus |
T580 | 1337-1341 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T579 | 1369-1378 | SP_7 | denotes | 2019-nCoV |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T145 | 60-68 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
T146 | 148-153 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T147 | 280-287 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T148 | 510-515 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T149 | 584-591 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T150 | 871-885 | Body_part | denotes | immunoglobulin | http://purl.org/sig/ont/fma/fma62871 |
T151 | 1015-1028 | Body_part | denotes | immune system | http://purl.org/sig/ont/fma/fma9825 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T16 | 1015-1028 | Body_part | denotes | immune system | http://purl.obolibrary.org/obo/UBERON_0002405 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T76 | 372-376 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T77 | 484-488 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T78 | 577-581 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T79 | 1186-1188 | Disease | denotes | NN | http://purl.obolibrary.org/obo/MONDO_0009747 |
T80 | 1223-1227 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T213 | 0-1 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T214 | 148-153 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T215 | 216-217 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T216 | 326-331 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T217 | 377-382 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T218 | 489-494 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T219 | 510-515 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T220 | 700-703 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T221 | 755-756 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T222 | 886-888 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
T223 | 902-904 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
T224 | 1015-1028 | http://purl.obolibrary.org/obo/UBERON_0002405 | denotes | immune system |
T225 | 1041-1046 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T226 | 1058-1064 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tested |
T227 | 1071-1077 | http://purl.obolibrary.org/obo/NCBITaxon_33208 | denotes | animal |
T228 | 1085-1086 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T229 | 1162-1167 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T230 | 1255-1256 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T231 | 1342-1344 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T86 | 74-82 | Chemical | denotes | molecule | http://purl.obolibrary.org/obo/CHEBI_25367 |
T87 | 280-287 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T88 | 584-591 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T89 | 957-965 | Chemical | denotes | molecule | http://purl.obolibrary.org/obo/CHEBI_25367 |
T90 | 989-997 | Chemical | denotes | effector | http://purl.obolibrary.org/obo/CHEBI_35224 |
T91 | 1186-1188 | Chemical | denotes | NN | http://purl.obolibrary.org/obo/CHEBI_73406 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T155 | 0-174 | Sentence | denotes | A potentially more promising strategy would be to create an antibody-like molecule that would bind to the coronavirus itself, rather than shielding cells from being infected. |
T156 | 175-344 | Sentence | denotes | For this strategy, it is proposed to use a soluble version of the ACE2 receptor that would bind to the S protein of 2019-nCoV thereby neutralizing the virus ( Figure 1). |
T157 | 345-431 | Sentence | denotes | Again, the research on the SARS virus suggests this strategy is potentially promising. |
T158 | 432-530 | Sentence | denotes | Soluble ACE2 receptor was demonstrated to block the SARS virus from infecting cells in culture 42. |
T159 | 531-730 | Sentence | denotes | The reported affinity of soluble ACE2 for the SARS S protein was 1.70 nM, which is comparable to the affinities of monoclonal antibodies 55; it is likely that 2019-nCoV has similar affinity for ACE2. |
T160 | 731-1047 | Sentence | denotes | In order to use ACE2 as a therapy to treat patients, it would be advisable to convert soluble ACE2 into an immunoadhesin format fused to an immunoglobulin Fc domain (ACE2-Fc), thereby extending the lifespan of the circulating molecule, while also recruiting effector functions of the immune system against the virus. |
T161 | 1048-1297 | Sentence | denotes | While not tested in an animal model, a previous study demonstrated that an ACE2 extracellular domain fused to the human IgG1 domain (ACE2-NN-Ig) was effective in neutralizing SARS coronavirus in vitro, with a 50% inhibitory concentration of 2 nM 56. |
T162 | 1298-1416 | Sentence | denotes | This study provides evidence then that ACE2-Fc could similarly inhibit 2019-nCoV in vitro and potentially in patients. |